Asthma
Pfizer to Acquire Coley Pharmaceutical Group
Published in Healthcare Finance, Tax and Law Weekly, December 5th, 2007
Under the terms of the agreement, Pfizer will make a cash tender offer for all of the outstanding common stock of Coley for $8.00 per share, representing an enterprise value of $164 million. The transaction is subject to customary closing conditions, including approval under the Hart-Scott-Rodino Antitrust Improvements Act of 1976...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Finance, Tax and Law Weekly
More Articles from Healthcare Finance, Tax and Law Weekly
- AARP
Divided We Fail 'Faith Week' to Raise Health and Financial Security Issues in Communities of Faith - Addiction Medicine
New findings from K.L. Benjamin and co-researchers in the area of addiction medicine described - Affiliated Computer Services, Inc.
ACS Awarded $35 Million Contract Extension for EMS Billing Services With City of Houston - Angioplasty
New Jersey Health Care Administration Board Votes for Continuation of Elective Angioplasty Demonstration Project - Aspreva Pharmaceuticals
Aspreva Sends Materials for Special Meeting to be Held December 17 - Bioethics
Reprogramming the debate: stem-cell finding alters ethical controversy - More from this issue of Healthcare Finance, Tax and Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
